Found: 17
Select item for more details and to access through your institution.
Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade.
- Published in:
- Integrative Cancer Therapies, 2016, v. 15, n. 3, p. 376, doi. 10.1177/1534735415611747
- By:
- Publication type:
- Article
SENP1-mediated deSUMOylation of JAK2 regulates its kinase activity and platinum drug resistance.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 4, p. 1, doi. 10.1038/s41419-021-03635-6
- By:
- Publication type:
- Article
Novel RNA aptamers targeting gastrointestinal cancer biomarkers CEA, CA50 and CA72-4 with superior affinity and specificity.
- Published in:
- PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0198980
- By:
- Publication type:
- Article
New Insights into Ferroptosis Initiating Therapies (FIT) by Targeting the Rewired Lipid Metabolism in Ovarian Cancer Peritoneal Metastases.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 23, p. 15263, doi. 10.3390/ijms232315263
- By:
- Publication type:
- Article
Orchestrated Action of AMPK Activation and Combined VEGF/PD-1 Blockade with Lipid Metabolic Tunning as Multi-Target Therapeutics against Ovarian Cancers.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 12, p. 6857, doi. 10.3390/ijms23126857
- By:
- Publication type:
- Article
The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 12, p. 6560, doi. 10.3390/ijms22126560
- By:
- Publication type:
- Article
Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells.
- Published in:
- Communications Biology, 2019, v. 2, n. 1, p. N.PAG, doi. 10.1038/s42003-019-0508-1
- By:
- Publication type:
- Article
AMPK Activators Suppress Cervical Cancer Cell Growth through Inhibition of DVL3 Mediated Wnt/β-Catenin Signaling Activity.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0053597
- By:
- Publication type:
- Article
Targeting GRB7/ERK/FOXM1 Signaling Pathway Impairs Aggressiveness of Ovarian Cancer Cells.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0052578
- By:
- Publication type:
- Article
Correction to: Genome-wide DNA methylome analysis identifies methylation signatures associated with survival and drug resistance of ovarian cancers.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Genome-wide DNA methylome analysis identifies methylation signatures associated with survival and drug resistance of ovarian cancers.
- Published in:
- Clinical Epigenetics, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13148-021-01130-5
- By:
- Publication type:
- Article
Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-022-01703-9
- By:
- Publication type:
- Article
SCD1/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells.
- Published in:
- Theranostics, 2022, v. 12, n. 7, p. 3534, doi. 10.7150/thno.70194
- By:
- Publication type:
- Article
Epigenetic Silencing of miR-33b Promotes Peritoneal Metastases of Ovarian Cancer by Modulating the TAK1/FASN/CPT1A/NF-κB Axis.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4795, doi. 10.3390/cancers13194795
- By:
- Publication type:
- Article
The Stress-Inducible BCL2A1 Is Required for Ovarian Cancer Metastatic Progression in the Peritoneal Microenvironment.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4577, doi. 10.3390/cancers13184577
- By:
- Publication type:
- Article
Targeting AMPK signaling in combating ovarian cancers: opportunities and challenges.
- Published in:
- Acta Biochimica et Biophysica Sinica, 2016, v. 48, n. 4, p. 301, doi. 10.1093/abbs/gmv128
- By:
- Publication type:
- Article
MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis.
- Published in:
- Molecular Cancer, 2017, v. 16, p. 1, doi. 10.1186/s12943-017-0582-2
- By:
- Publication type:
- Article